June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
A Family-based Investigation of the Role of TCF4 Trinucleotide Repeat Expansion in Fuchs Endothelial Corneal Dystrophy (FECD)
Author Affiliations & Notes
  • Keith Baratz
    Ophthalmology, Mayo Clinic, Rochester, MN
  • Ross Aleff
    BIochemistry and Molecular Biology, Mayo Clinic, Rochester, MN
  • Yi-Ju Li
    Biostatistics and BioInformatics, Center for Human Genetics, Duke University Medical Center, Durham, NC
  • Malinda Butz
    Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
  • Simon Gregory
    Medicine, Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC
  • Gordon Klintworth
    Ophthalmology, Duke University Medical Center, Durham, NC
  • W. Edward Highsmith
    Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
  • Natalie Afshari
    Ophthalmology, University of California, San Diego, San Diego, CA
  • Eric Wieben
    BIochemistry and Molecular Biology, Mayo Clinic, Rochester, MN
  • Footnotes
    Commercial Relationships Keith Baratz, Assessing the likelihood of developing Fuchs Corneal Dystrophy (P); Ross Aleff, Mayo Foundation (P); Yi-Ju Li, None; Malinda Butz, None; Simon Gregory, None; Gordon Klintworth, None; W. Edward Highsmith, None; Natalie Afshari, None; Eric Wieben, Assessing the likelihood of developing Fuchs Corneal Dystrophy (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4560. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Keith Baratz, Ross Aleff, Yi-Ju Li, Malinda Butz, Simon Gregory, Gordon Klintworth, W. Edward Highsmith, Natalie Afshari, Eric Wieben; A Family-based Investigation of the Role of TCF4 Trinucleotide Repeat Expansion in Fuchs Endothelial Corneal Dystrophy (FECD). Invest. Ophthalmol. Vis. Sci. 2013;54(15):4560. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Previous studies of unrelated FECD subjects and unaffected controls revealed a strong association between the presence of more than 50 repeats of the trinucleotide TGC in the third intron of the transcription factor 4 (TCF4) gene and the incidence of FECD. To evaluate the role of this triplet repeat in the inheritance of the disease, we examined whether this trinucleotide repeat expansion in TCF4 segregates with the incidence of FECD in families.

Methods: The corneas of FECD probands and their family members were graded by using a modified Krachmer scale (grade 0 - 6). Leukocyte-derived DNA was evaluated by fluorescence based short tandem repeat (STR) assays to calculate the TGC repeat length of both alleles in all affected and unaffected participants. Southern blot analysis was used to interrogate the repeat status in all DNA samples that had only a single allele by STR analysis. A total of 30 participants (33-91 years) from 11 families were included.

Results: The size of the trinucleotide repeat in patients with FECD ranged between 12 and 89 TGC repeats. Expansion above 50 repeats tracked with the disease in six of eleven families. In one additional family, 2 of 4 participants had FECD and repeat expansions of 59 and 62 TGC repeats, one member (48 yrs.) had equivocal disease with expansion (grade 1; 59 repeats), while the fourth family member (53 yrs.) had TGC expansion but no evidence of disease (gr. 0; 59 repeats). In the remaining four families, no repeat expansions above the 50 repeat threshold for disease association were identified in any of the seven affected (≥ gr. 2) and one equivocally affected (gr. 1) family members. Among families with expanded TGC repeats, the variation in repeat size was between 0 and 3 repeats in parent-child transmission and between 0 and 6 repeats between siblings.

Conclusions: Moderate expansions of the TGC repeat in TCF4 predicted FECD status in 6 of 11 FECD families. In a subset of FECD families, there was no expansion of this trinucleotide repeat. Thus, the repeat status may be useful and necessary in stratifying patients in further genetic studies of FECD and in studies of disease pathophysiology using FECD-affected tissue. In this small cohort, the expansion size varied minimally within families.

Keywords: 481 cornea: endothelium • 539 genetics • 479 cornea: clinical science  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×